We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+13.91%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$26.8B
AUM Growth
-$1.52B
(-5.4%)
Cap. Flow
-$4B
Cap. Flow
% of AUM
-14.9%
Top 10 Holdings %
Top 10 Hldgs %
57.68%
Holding
154
New
17
Increased
28
Reduced
47
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$122M |
| 2 |
KKR & Co
KKR
|
+$113M |
| 3 |
Fidelity National Information Services
FIS
|
+$105M |
| 4 |
ANSS
Ansys
ANSS
|
+$72.6M |
| 5 |
Shopify
SHOP
|
+$56.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$167M |
| 2 |
Alibaba
BABA
|
+$151M |
| 3 |
HubSpot
HUBS
|
+$144M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$143M |
| 5 |
COUP
Coupa Software Incorporated
COUP
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.89% |
| 2 | Consumer Discretionary | 5.08% |
| 3 | Financials | 4.6% |
| 4 | Industrials | 3.53% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JOYY
101
JOYY Inc
JOYY
$3.75B
| $23.6M | 0.09% |
447,000
-653,000
| -59% | -$38.5M |
|
102
Agios Pharmaceuticals
AGIO
$1.93B
| $23.5M | 0.09% |
491,615
-295,000
| -38% | -$11.1M |
|
|
TPTX
103
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $22.2M | 0.08% |
357,000
-200,000
| -36% | -$9.52M |
|
104
XP
XP
$8.39B
| $15.4M | 0.06% |
+400,000
| New | +$15M |
|
105
Unifirst Corp
UNF
$5.25B
| $12.1M | 0.05% |
60,000
+10,000
| +20% | +$2.03M |
|
|
APLT
106
DELISTED
Applied Therapeutics
APLT
| $12M | 0.04% |
440,039
+40,800
| +10% | +$699K |
|
107
TG Therapeutics
TGTX
$7.62B
| $11.1M | 0.04% |
+1,000,000
| New | +$7.6M |
|
|
AKRO
108
DELISTED
Akero Therapeutics
AKRO
| $9.76M | 0.04% |
439,594
-63,128
| -13% | -$1.31M |
|
109
Dianthus Therapeutics
DNTH
$6.09B
| $9.1M | 0.03% |
37,500
+6,250
| +20% | +$1.17M |
|
|
STML
110
DELISTED
Stemline Therapeutics, Inc.
STML
| $8.78M | 0.03% |
825,500
| – | – |
|
111
Datadog
DDOG
$84B
| $5.67M | 0.02% |
150,000
| – | – |
|
112
ServiceNow
NOW
$129B
| $5.65M | 0.02% |
100,000
| – | – |
|
113
Zoom
ZM
$30.6B
| $4.08M | 0.02% |
+60,000
| New | +$4.13M |
|
114
NetEase
NTES
$84.7B
| $2.77M | 0.01% |
45,095
| – | – |
|
115
Sarepta Therapeutics
SRPT
$1.77B
| $2.58M | 0.01% |
+20,000
| New | +$2.02M |
|
116
Neurogene
NGNE
$712M
| $2.46M | 0.01% |
+10,000
| New | +$996K |
|
117
Karyopharm Therapeutics
KPTI
$48M
| $2.4M | 0.01% |
+8,333
| New | +$1.81M |
|
118
Ascendis Pharma A/S
ASND
$16.8B
| $2.09M | 0.01% |
+15,000
| New | +$1.67M |
|
119
Sol-Gel Technologies
SLGL
$288M
| $1.92M | 0.01% |
+11,200
| New | +$967K |
|
|
ZEN
120
DELISTED
ZENDESK INC
ZEN
| $1.6M | 0.01% |
20,947
-2,280,153
| -99% | -$167M |
|
|
MDLA
121
DELISTED
Medallia, Inc.
MDLA
| $1.56M | 0.01% |
+50,000
| New | +$1.48M |
|
122
PayPal
PYPL
$50.5B
| $1.44M | 0.01% |
13,281
| – | – |
|
|
MYOK
123
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.09M | ﹤0.01% |
+15,000
| New | +$910K |
|
124
Zai Lab
ZLAB
$2.62B
| $1.04M | ﹤0.01% |
+25,000
| New | +$923K |
|
125
Costco
COST
$420B
| $800K | ﹤0.01% |
2,722
| – | – |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Alkeon Capital Management held 154 positions worth $26.8B, down 5.4% from $28.4B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Alkeon Capital Management withdrew a net $4B in Q4 2019, closing 21 positions and reducing 47 holdings. Its most notable exit was HubSpot, an estimated $144M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Alkeon Capital Management opened a new position in TSMC worth $134M.
- Alkeon Capital Management's largest Q4 2019 buy was TSMC: 2,300,000 shares worth $134M.
- Alkeon Capital Management added most to KKR & Co in Q4 2019, an estimated $113M increase.
- Alkeon Capital Management's biggest Q4 2019 reduction was ZENDESK INC, cutting an estimated $167M.
- Alkeon Capital Management fully exited HubSpot in Q4 2019, selling an estimated $144M.
- Alkeon Capital Management's ten largest holdings make up 58% of its $26.8B portfolio in Q4 2019.
- Alkeon Capital Management opened 17 new positions and closed 21 in Q4 2019.
- Alkeon Capital Management's portfolio value fell 5.4% quarter-over-quarter to $26.8B.
Based on Alkeon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.